Please assess the completion status of the following clinical trial:

Trial Title: Ketamine's Effect Changes the Cortical Electrophysiological Activity Related to Semantic Affective Dimension of Pain

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* male healthy subjects with higher education level~Exclusion Criteria:~* do not understand Portuguese language~* obese patients (BMI \> 27 kg/m2)~* use of NSAID, steroids, analgesics, anticonvulsant drugs, as well as alpha and beta-blockers~* score ≥ 13 on Beck II Questionnaire~* sleep deprivation in the night before evaluation

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 40 Years
- Healthy Volunteers: t

Study Arms:
- Group S-Ketamine (Type: EXPERIMENTAL): S-Ketamine will be diluted in normal saline and administrated in a target controlled infusion using an infusion pump to obtain a plasma target of 60 ng/ml according to Domino's model. Infusion will start during the interval between the 3rd and 4th blocks of the task.
- Group Placebo (Type: PLACEBO_COMPARATOR): A previously prepared identical solution containing only normal saline will be infused at the same infusion rates of group ketamine.

Based on this trial design, predict the completion outcome and termination type (if applicable).